Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge
LAS VEGAS, April 12, 2022 -- Gb Sciences, Inc. , a leading plant-inspired biopharmaceutical research and development company, has selected the University of Lethbridge in Canada to complete a... | April 12, 2022
Source: marketscreener.com